International leader in precision medicine to join Texas A&M through Governor’s University Research Initiative
Research suggests no single food can protect you from cancer, but a diet filled with vegetables, fruits, whole grains and beans helps lower the risk for many cancers. Dr. Roderick Dashwood is looking to reproduce the best parts of what we eat to stop cancer and other diseases before they even start.
Biological science phenom joins Texas A&M from Oxford, bringing cutting-edge techniques to “see” proteins as they interact with lipids
Arthur Laganowsky, Ph.D., a rising star in protein structural biology, has joined the Texas A&M Health Science Center Institute of Biosciences and Technology (IBT) in Houston’s Texas Medical Center. Laganowsky, the Nicholas Kurti Junior Research Fellow at the University of Oxford in world-renowned Dame Carol Robinson’s Laboratory, is the most recent faculty recruit for the Texas A&M Health Science Center IBT.
The Texas A&M University System Board of Regents today approved an initial two-year ground lease in Houston’s world-renowned Texas Medical Center to allow for expansion of the Texas A&M Health Science Center (TAMHSC) Houston campus and future construction of a multidisciplinary research and education building on the acquired land.
Researchers at the Texas A&M Health Science Center Institute of Biosciences and Technology in Houston have made a connection between a genetic defect and congenital hydrocephalus, a finding that may eventually lead to treatments for the neurological disease. The study is currently available online in Proceedings of the National Academy of Sciences and will be in an upcoming issue of the journal.
Through a series of recent studies, researchers at the Texas A&M Health Science Center Institute of Biosciences and Technology have demonstrated that fat cells are the specific target of an anti-stress, anti-obesity liver hormone – a finding that could help in the development of treatments for obesity.
Pulmotect, Inc. - a Houston-based biotechnology company co-founded by Magnus Höök, Ph.D., in the Texas A&M Health Science Center Institute of Biosciences and Technology - was chosen the best early stage investment opportunity at the recent Southeast BIO 2012 annual investor forum in Palm Beach, Fla.